What HCPs believe before it shows up in Rx data.

GNM turns real HCP behavior into intelligence that reveals readiness, resistance and adoption pathways early enough to act.

Scroll

Powering decisions for global pharmaceutical leaders

Strategic insight to help pharma lead their markets.

  1. See adoption shifts before they appear in Rx data

    Understand early signals in HCP behavior to anticipate changes in adoption long before traditional data confirms them.

  2. Identify HCPs who truly influence decisions

    Go beyond visibility to pinpoint the HCPs whose evidence-seeking behavior genuinely shapes peer decisions.

  3. Transform insight into strategy

    Turn decoded behavioral signals into clear, actionable strategies across the product lifecycle.

What makes GNM different

20+yrs

of trusted scientific content across 20+ therapeutic areas. The foundation every behavioral signal stands on.

Conviction Intelligence

A new category of pharma intelligence. The layer Rx data, market research and competitive intelligence cannot reach.

1.5M+

Verified HCPs across 6 regions. The infrastructure that makes Conviction Intelligence possible.

Enabling you to reach HCPs worldwide, with targeted selection by region and specialty.
World map showing GNM verified HCP distribution across 6 regions North America 739K, Latin America 173K, Europe 212K, MENA 94K, Africa 67K, APAC 215K. Total 1.5 million plus. North America 739K APAC 215K Europe 212K Latin America 173K MENA 94K Africa 67K

Where Conviction Intelligence sits

  • Rx data

    The receipt, not the decision

    Captures what’s done, not what’s forming

  • Market research

    What they tell you, not what they do

    Stated preference, decoupled from action

  • Conviction Intelligence

    Where physician belief forms

    Signals in real time, while decisions are still fluid

Most pharma data tells you what physicians did or said. Conviction Intelligence tells you what they believe, before it shows up in Rx data.

Strategic team reviewing pharmaceutical market analytics around a table

Your market is already telling you what's next.

Every day, HCPs leave behavioral signals across GNM ecosystems. We read them in real time to surface the conviction that drives launches, growth bets and strategic decisions.

See it in action

Where we operate

From signal to decision. One team.

GNM operates from Paris, Tokyo and New York — close enough to global pharma headquarters to brief in person, distributed enough to read each region on its own terms. HCP coverage and regional intelligence sit on the Network page.

Next step

Start with visibility. Add intelligence.

Unlock activation

30-minute conversation · NDA available on request · Tailored to your portfolio.